Autologous Mesenchymal Cell Therapy for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease that doesn’t just target your joints; it can affect other parts of your body too. Imagine dealing with persistent joint pain, swelling, and stiffness day in and day out—it’s not just uncomfortable, it can eventually lead to joint deformity and a loss of function. While traditional treatments like medications and physical therapy often help manage symptoms, they sometimes fall short of stopping the disease in its tracks. This has sparked growing interest in alternative treatments for RA, such as Autologous Mesenchymal Cell Therapy. At Plexus Neuro and Cell Research Center, we believe Autologous Mesenchymal Cell Therapy provides a new ray of hope for those looking for more effective ways to manage the disease.

Understanding Rheumatoid Arthritis (RA)

Rheumatoid arthritis is an autoimmune disorder where the body’s immune system mistakenly attacks its own tissues, specifically the synovium—the lining of the membranes that surround the joints. This immune system malfunction causes inflammation that can severely damage cartilage and bone within the joint. Over time, RA can result in joint deformity and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels.

Although the exact cause of RA remains unknown, genetic and environmental factors are believed to play a role. Common symptoms include:

• Tender, warm, swollen joints
• Morning stiffness that lasts for hours
• Fatigue
• Fever
• Loss of appetite

RA is a progressive disease, meaning it can worsen over time, making early diagnosis and treatment crucial to managing the condition effectively.

How Autologous Mesenchymal Cell Therapy Can Help Treat RA

Autologous Mesenchymal Cell-based Therapy for Rheumatoid Arthritis has emerged as a potential game-changer in the field of autoimmune disease treatment. Autologous Mesenchymal Cells are a type of Adult Regenerative Cells found in various tissues, including bone marrow, adipose tissue, and umbilical cord tissue. These cells have the unique ability to differentiate into various cell types, such as bone, cartilage, and fat cells, and they possess powerful anti-inflammatory and immunomodulatory properties.

The key to Autologous Mesenchymal Cell Therapy in RA lies in its ability to modulate the immune system, reducing the inappropriate immune response that drives the disease. Unlike traditional treatments that primarily focus on managing symptoms, Autologous Mesenchymal Cell Therapy targets the underlying cause of RA by promoting immune system balance, which can help to reduce inflammation, protect joints from further damage, and potentially induce remission.

How Autologous Mesenchymal Cell Therapy Works

The mechanism by which Autologous Mesenchymal Cell Therapy works in treating Rheumatoid Arthritis is multifaceted. Autologous Mesenchymal Cells exert their therapeutic effects through several pathways:

• Immunomodulation: Autologous Mesenchymal Cells can modulate the immune system by inhibiting the activity of pro-inflammatory T cells and promoting the expansion of regulatory T cells, which help maintain immune tolerance. This can prevent the immune system from attacking healthy tissues, reducing the inflammation that characterizes RA.
• Anti-inflammatory effects: Autologous Mesenchymal Cells secrete various anti-inflammatory cytokines and growth factors that help to reduce inflammation in the joints. This not only alleviates pain and swelling but also prevents further joint damage.
• Tissue repair and regeneration: Autologous Mesenchymal Cells have the ability to differentiate into various cell types, including chondrocytes (cartilage cells) and osteoblasts (bone cells). This regenerative capacity allows Autologous Mesenchymal Cells to contribute to the repair of damaged joint tissues, potentially reversing some of the damage caused by RA.
• Paracrine signaling: Autologous Mesenchymal Cells release extracellular vesicles and exosomes that carry bioactive molecules. These molecules can enhance the regenerative processes in damaged tissues and further modulate the immune response, providing an additional layer of therapeutic effect.

Benefits of Autologous Mesenchymal Cell Therapy in RA Management

Autologous Mesenchymal Cell Therapy for Rheumatoid Arthritis offers several potential benefits that make it an attractive alternative treatment for RA:

1. Targeted therapy: Autologous Mesenchymal Cell Therapy targets the underlying cause of RA—the dysregulated immune response—rather than just addressing the symptoms. This approach can lead to more effective and lasting relief from RA symptoms.
2. Reduced side effects: Traditional RA treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs), can have significant side effects with long-term use. Autologous Mesenchymal Cell Therapy is generally well-tolerated and associated with fewer adverse effects.
3. Potential for remission: By modulating the immune system and promoting tissue repair, Autologous Mesenchymal Cell Therapy has the potential to induce long-term remission in RA patients. This means that patients could experience extended periods without active disease symptoms, improving their quality of life.
4. Minimal invasiveness: Autologous Mesenchymal Cell Therapy is typically administered through intra-articular injections (directly into the joint) or intravenous infusions. These procedures are minimally invasive and can be performed on an outpatient basis, making the treatment accessible and convenient for patients.
5. Regenerative properties: The ability of Autologous Mesenchymal Cells to differentiate into cartilage and bone cells provides an opportunity for not just halting disease progression but also reversing some of the damage already done by RA, offering hope for restoring joint function and reducing disability.

Procedure and Protocols for Autologous Mesenchymal Cell Therapy in Rheumatoid Arthritis

The procedure for Autologous Mesenchymal Cell Therapy for Rheumatoid Arthritis involves several steps, each designed to ensure the safety and efficacy of the treatment.

1. Patient Selection: Not all RA patients may be suitable candidates for Autologous Mesenchymal Cell Therapy. Physicians typically evaluate factors such as the stage of the disease, the patient’s overall health, and previous response to other treatments to determine eligibility.
2. Autologous Mesenchymal Cell Sourcing: Autologous Mesenchymal Cells can be derived from various sources, including bone marrow, adipose tissue, and umbilical cord tissue. The choice of source may depend on factors such as the availability of tissue, the patient’s preference, and the specific protocols of the treatment center.
3. Autologous Mesenchymal Cell Isolation and Expansion: Once the Autologous Mesenchymal Cells are harvested, they are isolated and expanded in a laboratory setting. This process involves culturing the cells to increase their numbers while ensuring their viability and potency. The quality and safety of the expanded Autologous Mesenchymal Cells are rigorously tested before they are used in therapy.
4. Administration: Autologous Mesenchymal Cells can be administered via intra-articular injection directly into the affected joints or through intravenous infusion, depending on the extent of the disease and the treatment protocol. In some cases, a combination of both methods may be used to maximize the therapeutic effects.
5. Post-Treatment Monitoring: After Autologous Mesenchymal Cell Therapy, patients are closely monitored for any adverse reactions and to assess the efficacy of the treatment. Follow-up visits typically include physical examinations, imaging studies, and laboratory tests to track improvements in joint function and reductions in inflammation.

Risks of Autologous Mesenchymal Cell Therapy

At our centers in Bangalore and Hyderabad, we offer minimally invasive, risk-free Autologous Mesenchymal Cell Therapy for RA.

By harnessing the regenerative and immunomodulatory properties of Autologous Mesenchymal Cells, this therapy offers the potential to not only manage symptoms but also address the underlying causes of the disease. Living with Rheumatoid Arthritis can be challenging, but it’s important to remember that you’re not alone, and there are always new options emerging to help manage the condition. Autologous Mesenchymal Cell Therapy offers a glimpse of hope, with its potential to not only ease your symptoms but also address the underlying causes of RA.

As you explore your treatment options, take comfort in knowing that progress is being made every day, and there’s a growing arsenal of therapies designed to improve your quality of life. Reach out to Team Plexus to know more, and most importantly, hold on to hope—better days are possible.

WhatsApp +91 89048 42087

Call +91 78159 64668 (Hyderabad) | +91 82299 99888 (Bangalore)

FAQs

How much does Cell therapy cost for rheumatoid arthritis?

At Plexus, we offer customized rehabilitation programs for rheumatoid arthritis. We do our best to devise a treatment plan that fits within your budget. Do reach out to us today to understand more.

WhatsApp +91 89048 42087

Call +91 78159 64668 (Hyderabad) | +91 82299 99888 (Bangalore)

Are Autologous Mesenchymal Cells in Rheumatoid Arthritis the good or bad guys?

Autologous Mesenchymal Cells are the “good guys” in Rheumatoid Arthritis therapy. They have the potential to regulate the immune response, reduce inflammation, and promote tissue repair. Unlike traditional treatment approaches, Autologous Mesenchymal Cell Therapy targets the disease’s underlying causes rather than just alleviating symptoms.

Can Cell therapy cure RA?

Cell therapy can help manage symptoms, reduce inflammation, and slow disease progression. 

How many years can I live with rheumatoid arthritis?

With proper management, you can live a normal lifespan up to its fullest potential. Early diagnosis and effective treatment are key to preventing severe joint damage and complications, allowing you to maintain a good quality of life for many years.

What foods are bad for rheumatoid arthritis?

Foods that can worsen rheumatoid arthritis include:

• Processed foods
• Sugary snacks
• Red meat
• Fried foods

These can trigger inflammation and exacerbate symptoms. Your diet should be rich in anti-inflammatory foods like fruits, vegetables, whole grains, and omega-3-rich fish.